These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function. Lv P; Zhao M; Liu Y; Jin H; Cui W; Fan C; Teng Y; Zheng L; Huang Y Int J Mol Med; 2018 Jan; 41(1):61-68. PubMed ID: 29115584 [TBL] [Abstract][Full Text] [Related]
3. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. Vaziri ND; Navab K; Gollapudi P; Moradi H; Pahl MV; Barton CH; Fogelman AM; Navab M J Natl Med Assoc; 2011 Jun; 103(6):524-33. PubMed ID: 21830637 [TBL] [Abstract][Full Text] [Related]
4. Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study. Okubo K; Ikewaki K; Sakai S; Tada N; Kawaguchi Y; Mochizuki S J Am Soc Nephrol; 2004 Apr; 15(4):1008-15. PubMed ID: 15034103 [TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis. Navarro JF; Mora C; Muros M; García-Idoate G Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274 [TBL] [Abstract][Full Text] [Related]
6. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. Yamamoto S; Yancey PG; Ikizler TA; Jerome WG; Kaseda R; Cox B; Bian A; Shintani A; Fogo AB; Linton MF; Fazio S; Kon V J Am Coll Cardiol; 2012 Dec; 60(23):2372-9. PubMed ID: 23141484 [TBL] [Abstract][Full Text] [Related]
7. Alterations in lipoprotein composition in peritoneal dialysis patients. Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407 [TBL] [Abstract][Full Text] [Related]
8. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis. Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284 [TBL] [Abstract][Full Text] [Related]
9. Uremia alters HDL composition and function. Holzer M; Birner-Gruenberger R; Stojakovic T; El-Gamal D; Binder V; Wadsack C; Heinemann A; Marsche G J Am Soc Nephrol; 2011 Sep; 22(9):1631-41. PubMed ID: 21804091 [TBL] [Abstract][Full Text] [Related]
15. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [TBL] [Abstract][Full Text] [Related]